Thermo Fisher Scientific Inc.

05/26/2026 | Press release | Distributed by Public on 05/26/2026 05:31

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders
At the Annual Meeting held on May 20, 2026, the shareholders of the Company voted on the following proposals:
1. The following nominees were elected to the Company's Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.
For Against Abstain
Marc N. Casper 294,015,478 20,501,640 1,202,257
Nelson J. Chai 293,142,241 21,615,744 961,390
Ruby R. Chandy
312,259,374 2,490,403 969,598
C. Martin Harris 285,543,740 28,753,064 1,422,571
Tyler Jacks 304,372,357 10,373,697 973,321
Jennifer M. Johnson
304,583,443 10,151,215 984,717
R. Alexandra Keith 308,290,311 6,269,824 1,159,240
Karen S. Lynch 308,933,071 5,811,374 974,930
Debora L. Spar 314,426,121 311,821 981,433
Scott M. Sperling 292,218,754 22,524,675 975,946
Dion J. Weisler 281,791,656 32,960,105 967,614
2. A non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved.
For Against Abstain
99,928,178 214,525,673 1,265,524
3. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified.
For Against Abstain
296,866,709 36,064,900 999,237
Thermo Fisher Scientific Inc. published this content on May 26, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 26, 2026 at 11:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]